Guidance on Handling the Increasing Prevalence of Drugs Adulterated or Laced with Fentanyl
This paper offers principle and recommendations for remediating the impacts of the rising rates of drugs adulterated or laced with fentanyl.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
This paper offers principle and recommendations for remediating the impacts of the rising rates of drugs adulterated or laced with fentanyl.
This playbook section provides health information technology (IT) guidance for specialists, including guidance on health information exchange and electronic health record workflow tools, case studies, and best practices.
This toolkit provides a step-by-step guide for introducing pharmacotherapy for co-occurring mental health and substance use disorders, including a workflow map and roles and responsibilities for all team members, including primary care.
As part of the AcademyHealth's series highlighting takeaways from the 13th Annual Conference on the Science of Dissemination and Implementation in Health, this blog post explores opportunities and challenges of remote implementation facilitation and shares best practices for effective engagement during and after the pandemic.